glp-1 anti-obesity signaling pathway in obesity pathogenesis. The CMS Issues Coverage Guidance on

It has anti-cancer drug properties, it decreases cell cycle proliferation and then it inhibits mitochondrial respiratory complex I

These drugs also are helpful for people with sleep apnea, which is associated with high blood pressure and increased cardiac risk

He is also concerned about the mental health of young people taking GLP-1s

The Future of GLP-1 Therapy in India In India, semaglutide and liraglutide are now available for both diabetes and obesity treatment

The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction - PMC

If these medications are stopped, then the weight comes back, and even weight gain can occur, so this is one of the challenges with why these medications are often not covered, he said